We are a late-stage pharmaceutical company focused on utilizing our proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs, with an initial focus on diseases of the central nervous system, or CNS.
$14.00 - $16.00
April 23, 2021
COWEN AND COMPANY, LLC
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Impel NeuroPharma IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277